Front Cover: Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance (ChemMedChem 2/2023)

Overview of attention for article published in ChemMedChem, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 4 X users

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 9,673 followers.

RT @chemlibcam: New #camchempub from @RaduNicolescu4 @SpringGroupChem @dr_illo at @ChemCambridge and collaborators.

New #camchempub from @RaduNicolescu4 @SpringGroupChem @dr_illo at @ChemCambridge and collaborators.

RT @ChemMedChem: #OnTheCover Front Cover: Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Pro…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.